- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SCD1, autophagy and cancer: implications for therapy ; volume:40 ; number:1 ; day:24 ; month:8 ; year:2021 ; pages:1-16 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (24.8.2021), 1-16, 12.2021
- Creator
-
Ascenzi, Francesca
De Vitis, Claudia
Maugeri-Saccà, Marcello
Napoli, Christian
Ciliberto, Gennaro
Mancini, Rita
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-02067-6
- URN
-
urn:nbn:de:101:1-2021110918454663505927
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ascenzi, Francesca
- De Vitis, Claudia
- Maugeri-Saccà, Marcello
- Napoli, Christian
- Ciliberto, Gennaro
- Mancini, Rita
- SpringerLink (Online service)
Other Objects (12)
Emerging therapeutics
The perfect personalized cancer therapy: cancer vaccines against neoantigens
Research Choices: Time for Europe to Decide
Cancer patients and coronavirus disease 2019: evidence in context
Drug repurposing against COVID-19: focus on anticancer agents
Tumor biobanks in translational medicine
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
Autophagy in cancer therapy
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research
Emerging therapeutics
The perfect personalized cancer therapy: cancer vaccines against neoantigens
Research Choices: Time for Europe to Decide
Cancer patients and coronavirus disease 2019: evidence in context
Drug repurposing against COVID-19: focus on anticancer agents
Tumor biobanks in translational medicine
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
Autophagy in cancer therapy
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research
Emerging therapeutics
The perfect personalized cancer therapy: cancer vaccines against neoantigens
Research Choices: Time for Europe to Decide
Cancer patients and coronavirus disease 2019: evidence in context
Drug repurposing against COVID-19: focus on anticancer agents
Tumor biobanks in translational medicine
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
Autophagy in cancer therapy
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization